Advertisement Embria EpiCor completes FDA NDI process - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Embria EpiCor completes FDA NDI process

Embria Health Sciences, a provider of health products, has completed the US Food and Drug Administration's New Dietary Ingredient (NDI) notification process for its ingredient, EpiCor.

EpiCor is a natural product that helps in the maintenance of the immune system.

The clinical studies have demonstrated EpiCor’s immune-balancing properties in helping the body boost or suppress immune response as required.

Embria Health Sciences regulatory counsel Kevin Boot said EpiCor received a clean acknowledgement letter that means all populations can take EpiCor year round.

”The safety of EpiCor confirmed there’s no concern about immune fatigue, which can be a concern for other immune ingredients," Boot added.